Association of CACNA1C polymorphisms (rs1006737, rs4765905, rs2007044) with schizophrenia: A meta-analysis and trial sequential analysis.

Saurav Sharma, Aditya K Panda, Surjyapratap Sarangi, Suraj Kumar Nahak

Journal: Schizophrenia research 2024;274():247-256

PMID: 39378823

Abstract

Schizophrenia is a complex neurological disorder characterized by significant impairment in the perception of reality and changes in behavior. Genetic and environmental factors influence the development of schizophrenia. CACNA1C, which encodes a subunit of a voltage-dependent calcium channel, has been associated with various neurological disorders, including schizophrenia. Several studies have been performed in different populations to explore the association of common genetic variants in the CACNA1C gene with susceptibility to the development of schizophrenia, but results remain contradictory. To draw a definitive conclusion on the association between CACNA1C polymorphisms and schizophrenia, we conducted a meta-analysis focusing on three commonly studied polymorphisms: rs1006737, rs4765905, and rs2007044. For the meta-analysis, a comprehensive literature search was performed using PubMed, Scopus, Science Direct and Google Scholar databases. Data was retrieved, and the meta-analysis was performed using CMA v4 software. The meta-analysis revealed a significant association between rs1006737 and rs2007044 and schizophrenia in the overall population, while no such association was found for rs4765905. Population-wise analysis suggested that all three polymorphisms were significantly associated with schizophrenia in the Asian population and that rs1006737 was significantly associated with schizophrenia in Europeans. We also performed a Trial Sequential Analysis (TSA), which supported our findings. Some report-based assay studies have suggested a role for these polymorphisms in schizophrenia, but further case-control studies are needed to confirm the association of rs4765905 and rs2007044 with the disorder.

Copyright © 2024 Elsevier B.V. All rights reserved.

Address: ImmGen EvSys Laboratory BT-113, Department of Biotechnology, Berhampur University, Bhanja Bihar, Berhampur, Odisha 760007, India; Department of Biosciences and Biomedical Engineering, Indian Institute of Technology, Indore 453552, India.; Department of Biosciences and Biomedical Engineering, Indian Institute of Technology, Indore 453552, India.; ImmGen EvSys Laboratory BT-113, Department of Biotechnology, Berhampur University, Bhanja Bihar, Berhampur, Odisha 760007, India.; ImmGen EvSys Laboratory BT-113, Department of Biotechnology, Berhampur University, Bhanja Bihar, Berhampur, Odisha 760007, India; Centre of Excellence on Bioprospecting of Ethno-pharmaceuticals of Southern Odisha (CoE-BESO), Berhampur University, Bhanja Bihar, Berhampur, Odisha 760007, India. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.